Russian Family DoctorRussian Family Doctor2072-16682713-2331Eco-Vector10830310.17816/RFD108303Research ArticleReactivation of chronic brucellosis infection after COVID-19 (case report)KhaidarovaYulduz M.<p>doctoral student 3 years of study</p>yulduz.khaidarova88@gmail.comhttps://orcid.org/0000-0002-5475-8410LesnyakOlga M.<p>MD, Dr. Sci. (Med.), Professor</p>olga.m.lesnyak@yandex.ruhttps://orcid.org/0000-0002-0143-0614KurmanovaGaukhar M.<p>MD, Dr. Sci. (Med.), Professor</p>gkurman@mail.ruhttps://orcid.org/0000-0002-5768-0209KulembaevaAnarkul B.<p>MD, Cand. Sci. (Med.)</p>dr_kulembayeva@mail.ruhttps://orcid.org/0000-0003-3513-8467Al-Farabi Kazakh National UniversityCity Rheumatology Centerorth-Western State Medical University named after I.I. Mechnikov1011202226337422805202209092022Copyright © 2022, Eco-Vector2022<p>It has been proven that the SARS-CoV-2 virus, interacting with persistent latent pathogens in the human body, including those living in the ecosystems of the intestine, mouth and lungs, causes dysregulation of the immune system and can contribute to the reactivation of these pathogens. The authors of the article suggested this pathogenic virus can play the role of a superantigen and trigger the phenomenon of polyclonal activation of lymphocytes, due to which various clones of lymphocytes may be activated, thereby giving impetus to the reactivation of a chronic persistent infection. This article describes a clinical case of a patient who had previously undergone an effectively treated form of chronic brucellosis in history, with signs of reactivation of brucellosis infection detected after infection with the SARS-CoV-2 virus, confirmed by clinical laboratory and instrumental studies.</p>
<p><br /><br /></p>chronic brucellosisCOVID-19reactivation of a chronic infectionхронический бруцеллезCOVID-19реактивация хронической инфекции[WHO [Internet]. Available from: https://covid19.who.int/. Accessed: 09.09.2022.][Khaidarova YuM, Kurmanova GM, Seizhanova BB, Kurmanbekova MB. Difficulties of differential diagnosis of early seronegative spondyloarthritis in an endemic brucellosis zone. Sovremennaya nauka: aktual’nye problemy teorii i praktiki. 2021;(11).208–214. (In Russ.). DOI: 10.37882/2223–2966.2021.11.37][Güven M. Brucellosis in a patient diagnosed with Coronavirus Disease 2019 (COVID-19). J Infect Dev Ctries. 2021;15(8):1104–1106. DOI: 10.3855/jidc.13899][Kurmanova KB, Duisenova AK. Brutsellez. Klinicheskie aspekty. Almaty; 2002. 252 p. (In Russ.)][Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169. DOI: 10.3389/fmicb.2021.698169][Alekseeva LI. Сlinical guidelines update on the treatment of patients with osteoarthritis in 2019. RMJ. 2019;27(4):2–6. (In Russ.)][Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155–162. DOI: 10.1097/BOR.0000000000000776][Wylie KM, Mihindukulasuriya KA, Zhou Y, et al. Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Med. 2014;12:71. DOI: 10.1186/s12915-014-0071-7]